-
1.发明申请AMIDOMETHYL-SUBSTITUTED 2-(4-SULFONILAMINO)-3-HIDROXY-3,4-DIHYDRO-2H-CHROMIUM-6-YL-DERIVATIVES AND DRUGS CONTAINING SAID COMPOUNDS 审中-公开酰氨基甲基取代的2-（4- SULFONILAMINO）-3- HIDROXY -3,4-二氢-2H-色烯-6-基衍生物，制备方法和中间体FOR THEIR及药物含有这些化合物的
公开(公告)号：WO2005037780A2
公开(公告)日：2005-04-28
申请号：PCT/EP2004052539
申请日：2004-10-14
Applicant: SOLVAY PHARM GMBH
Inventor： SYKES DAVID , MOLONEY BRIAN , MARRISON LESTER , ZIEGLER DIETER , MLINARIC MICHAEL , BOECKER CHRISTIANE , BRUECKNER REINHARD , WESKE MICHAEL , WITTE KLAUS , FISCHER YVAN
IPC: A61K31/353 , C07D311/68 , C07D407/12 , C07D
CPC classification number: C07D407/12 , C07D311/68
Abstract: The invention relates to compounds of general formula (I), wherein the meaning of R , R , R , R , R and R is given in a description, to a method for producing said compounds and to intermediate products thereof. Drugs containing the inventive compounds of formula (1) are also disclosed.
Abstract translation: 有通式（I）的化合物，其中，R <1>，R <2>，R <3>，R <4>，R <5>和R <6>具有在说明书中给出，以及一个的含义 一种用于这些化合物并描述这个过程的中间产物的制备方法。 此外，可以给出含有它们的式（I）的药物组合物的化合物。
-
2.发明申请NOVEL C11 MODIFIED RETROSTEROIDS AS PROGESTERONE RECEPTOR MODULATOR COMPOUNDS 审中-公开新型C11改性复方作为孕激素受体调节剂化合物
公开(公告)号：WO2008113851A3
公开(公告)日：2008-11-20
申请号：PCT/EP2008053365
申请日：2008-03-20
Applicant: SOLVAY PHARM GMBH , MESSINGER JOSEF , BOECKER CHRISTIANE , HUSEN BETTINA , THOLE HEINRICH-HUBERT , HINAJE MARIA , BUCHHOLZ MONIKA
Inventor： MESSINGER JOSEF , BOECKER CHRISTIANE , HUSEN BETTINA , THOLE HEINRICH-HUBERT , HINAJE MARIA , BUCHHOLZ MONIKA
CPC classification number: C07J15/005
Abstract: Described herein arenew retrosteroidal compounds of general formula (I), representing progesterone receptor modulators, and their production, and pharmaceutical preparations containing these compounds. Saidcompounds are preferably used for the treatment of benign gynecological disorders such as endometriosis and uterine fibroids, as well as for female birth control and for HRT.
Abstract translation: 本文描述了代表孕酮受体调节剂及其制备的通式（I）的新型逆甾体化合物和含有这些化合物的药物制剂。 所述化合物优选用于治疗良性妇科疾病，例如子宫内膜异位症和子宫肌瘤，以及用于女性避孕和HRT。
-
公开(公告)号：AU2004281195B2
公开(公告)日：2010-12-16
申请号：AU2004281195
申请日：2004-10-14
Applicant: SOLVAY PHARM GMBH
Inventor： MOLONEY BRIAN , WESKE MICHAEL , SYKES DAVID , FISCHER YVAN , MLINARIC MICHAEL , BOECKER CHRISTIANE , BRUECKNER REINHARD , WITTE KLAUS , MARRISON LESTER , ZIEGLER DIETER
IPC: C07D307/00 , A61K31/353 , A61P9/06 , C07D311/00 , C07D311/68 , C07D407/12
Abstract: The invention relates to compounds of general formula (I), wherein the meaning of R 1 , R 2 , R 3 , R 4 , R 5 and R 6 is given in a description, to a method for producing said compounds and to intermediate products thereof. Drugs containing the inventive compounds of formula (1) are also disclosed.
-
公开(公告)号：NO20075766L
公开(公告)日：2007-11-09
申请号：NO20075766
申请日：2007-11-09
Applicant: SOLVAY PHARM GMBH
Inventor： ZIEGLER DIETER , WESKE MICHAEL , FISCHER YVAN , MOLONEY BRIAN , MARRISON LESTER , MLINARIC MICHAEL , BOECKER CHRISTIANE , BRUECKNER REINHARD , WITTE KLAUS
IPC: C07D311/68 , C07D405/12
Abstract: Cardiovascular active compounds of the general formula (I), wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 10 and n have the meanings given in the description, and also a process for the preparation of these compounds and intermediate products of this process are described. Furthermore, pharmaceutical compositions comprising the compounds of Formula (I) are specified.
-
公开(公告)号：MX2007011198A
公开(公告)日：2007-10-17
申请号：MX2007011198
申请日：2006-04-11
Applicant: SOLVAY PHARM GMBH
Inventor： FISCHER YVAN , ZIEGLER DIETER , WESKE MICHAEL , MOLONEY BRIAN , MARRISON LESTER , MLINARIC MICHAEL , BOECKER CHRISTIANE , BRUECKNER REINHARD , WITTE KLAUS
IPC: C07D311/68 , A61K31/353 , A61K31/4025 , A61K31/453 , A61K31/497 , A61K31/5355 , A61P9/00 , C07D405/12 , C07D413/12
Abstract: Se describen compuestos activos cardiovascularmente de la formula general I, (ver formula I) en la que R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, y n tienen los significados dados en la parte descriptiva, y tambien un procedimiento para la preparacion de estos compuestos y productos intermedios de este procedimiento. Ademas, se especifican composiciones farmaceuticas que comprenden compuestos de la formula I.
-
Patent Agency Ranking
公开(公告)号：NO20062202L
公开(公告)日：2006-07-03
申请号：NO20062202
申请日：2006-05-16
Applicant: SOLVAY PHARM GMBH
Inventor： ZIEGLER DIETER , WESKE MICHAEL , FISCHER YVAN , SYKES DAVID , MOLONEY BRIAN , MARRISON LESTER , MLINARIC MICHAEL , BOECKER CHRISTIANE , BRUECKNER REINHARD , WITTE KLAUS
IPC: C07D311/68 , A61K31/353 , C07D407/12
Abstract: The invention relates to compounds of general formula (I), wherein the meaning of R 1 , R 2 , R 3 , R 4 , R 5 and R 6 is given in a description, to a method for producing said compounds and to intermediate products thereof. Drugs containing the inventive compounds of formula (1) are also disclosed.
-
公开(公告)号：NO20062202A
公开(公告)日：2006-07-03
申请号：NO20062202
申请日：2006-05-16
Applicant: SOLVAY PHARM GMBH
Inventor： ZIEGLER DIETER , WESKE MICHAEL , FISCHER YVAN , SYKES DAVID , MOLONEY BRIAN , MARRISON LESTER , MLINARIC MICHAEL , BOECKER CHRISTIANE , BRUECKNER REINHARD , WITTE KLAUS
IPC: C07D311/68 , A61K31/353 , C07D407/12
CPC classification number: C07D407/12 , C07D311/68
-
公开(公告)号：ES2313126T3
公开(公告)日：2009-03-01
申请号：ES04817204
申请日：2004-10-14
Applicant: SOLVAY PHARM GMBH
Inventor： SYKES DAVID , MOLONEY BRIAN , MARRISON LESTER , ZIEGLER DIETER , MLINARIC MICHAEL , BOECKER CHRISTIANE
IPC: C07D201/00 , A61K31/353 , C07D311/68 , C07D407/12
Abstract: Compuestos de la fórmula general I, (Ver fórmula) en donde, R 1 significa alquilo C1 - 4, R 2 significa alquilo C1 - 4, R 3 significa fenilo, que está eventualmente sustituido, 1-2 veces, con halógeno, alquilo C1 - 4, alcoxi C1 - 4 o trifluorometilo; naftilo o bifenilo, R 4 significa hidrógeno; alquilo C1 - 6 o cicloalquil C3 - 7-alquilo C1 - 4, R 5 significa hidrógeno y R 6 significa alquilo C1 - 6; fenil-alquilo C1 - 4, cuyo grupo fenilo está eventualmente sustituido 1 vez con halógeno; furil-alquilo C1 - 4 o tetrahidronaftilo, o R 5 y R 6 , junto con el nitrógeno al que están unidos, forman un anillo de piperazina el cual está eventualmente sustituido con fenilo.
-
公开(公告)号：HK1116167A1
公开(公告)日：2008-12-19
申请号：HK08105447
申请日：2008-05-16
Applicant: SOLVAY PHARM GMBH
Inventor： MOLONEY BRIAN , MARRISON LESTER , ZIEGLER DIETER , MLINARIC MICHAEL , BOECKER CHRISTIANE , WESKE MICHAEL , WITTE KLAUS , FISCHER YVAN , BRUECKNER REINHARD
IPC: A61K20060101 , A61P20060101 , C07D20060101
Abstract: Cardiovascular active compounds of the general formula (I), wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 10 and n have the meanings given in the description, and also a process for the preparation of these compounds and intermediate products of this process are described. Furthermore, pharmaceutical compositions comprising the compounds of Formula (I) are specified.
-
公开(公告)号：AT405547T
公开(公告)日：2008-09-15
申请号：AT04817204
申请日：2004-10-14
Applicant: SOLVAY PHARM GMBH
Inventor： SYKES DAVID , MOLONEY BRIAN , MARRISON LESTER , ZIEGLER DIETER , MLINARIC MICHAEL , BOECKER CHRISTIANE , BRUECKNER REINHARD , WESKE MICHAEL , WITTE KLAUS , FISCHER YVAN
IPC: C07D201/00 , A61K31/353 , C07D311/68 , C07D407/12
Abstract: The invention relates to compounds of general formula (I), wherein the meaning of R 1 , R 2 , R 3 , R 4 , R 5 and R 6 is given in a description, to a method for producing said compounds and to intermediate products thereof. Drugs containing the inventive compounds of formula (1) are also disclosed.
-
-
-
-
-
-
-
-
-
Search Results
29
records
(took 0.023 seconds)
